Novo Nordisk Pharmaceutical Sales Reps File $70 Million Wage and Hour Class Action

New York, NY: A $70 million class and collective action complaint has been filed in the U.S. District Court for the Southern District of New York (SDNY) on behalf of two plaintiffs and a class of sales representatives ("reps") currently or formerly employed by Danish Pharmaceutical manufacturer, Novo Nordisk, Inc. The complaint demands $70 million in overtime pay and charges that Novo willfully fails to pay the reps overtime wages as required by New York and federal law.

Plaintiffs are New Jersey resident McKenzie Stepe and Texas resident Karen Woolen. The two pharmaceutical sales representatives were required to work more than 40 hours a week by the company, but were never paid the overtime compensation dictated by the Fair Labor Standards Act (FLSA) and/or New York overtime laws.

Two classes of employees are defined in the complaint: The FSLA class includes all Novo Nordisk sales representatives employed in any state or territory of the U.S. from March 2009 until the present, and the New York State law class includes all sales reps who worked for the company in New York for at least one day from March 2006 to the present who do not opt out of the action.

Novo Nordisk Unpaid Overtime Class Action Legal Help

If you or a loved one has suffered damages in this case, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Published on Mar-5-12